INT210221

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.45
First Reported 2007
Last Reported 2010
Negated 2
Speculated 1
Reported most in Body
Documents 4
Total Number 4
Disease Relevance 2.08
Pain Relevance 0.42

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (Cd34) cell adhesion (Cd34) cytoplasm (Cd34)
Anatomy Link Frequency
blood 1
stem cells 1
Cd34 (Mus musculus)
Pain Link Frequency Relevance Heat
cytokine 17 97.32 Very High Very High Very High
Pain 6 94.72 High High
Inflammation 27 84.32 Quite High
Analgesic 2 81.44 Quite High
Paracetamol 2 79.84 Quite High
withdrawal 2 46.96 Quite Low
antagonist 2 31.92 Quite Low
Multiple sclerosis 2 12.36 Low Low
ischemia 18 5.00 Very Low Very Low Very Low
agonist 5 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disease 8 97.40 Very High Very High Very High
Pain 6 94.72 High High
Myalgia 4 94.24 High High
Vomiting 2 92.56 High High
Congenital Anomalies 9 90.76 High High
Cancer 61 86.80 High High
Colon Cancer 35 85.36 High High
Neurological Disease 2 84.64 Quite High
INFLAMMATION 30 84.32 Quite High
Enteropathy 1 74.52 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In this study, we found that the dosage of twice daily G-CSF administration and the total processed blood volume did not affect the CD34+ yield.
Neg (not) Regulation (affect) of CD34 in blood
1) Confidence 0.45 Published 2010 Journal Transfusion Medicine (Oxford, England) Section Body Doc Link PMC2871169 Disease Relevance 0.19 Pain Relevance 0
The BM harvest was performed in our study and was found that age was negatively correlated with CD34+ yield, whereas pre-BM collection CIC counts were positively correlated with CD34+ yield, and G-CSF dose, total processed BM volume and pre-BM collection WBC did not affect the CD34+ yield.
Neg (not) Regulation (affect) of CD34
2) Confidence 0.45 Published 2010 Journal Transfusion Medicine (Oxford, England) Section Body Doc Link PMC2871169 Disease Relevance 0.46 Pain Relevance 0.26
One of the authors (FS) has utilized both CD34+ and mesenchymal stem cells clinically for treatment of various diseases.
Regulation (utilized) of CD34 in stem cells associated with disease
3) Confidence 0.41 Published 2007 Journal J Transl Med Section Body Doc Link PMC1914111 Disease Relevance 0.83 Pain Relevance 0.17
EA conceived of the study, coordinated the research, performed and analysed CD34, VEGF, PLA2, and iNOS staining, VEGF ELISA, CFSE and PI staining, and wrote the manuscript.
Spec (analysed) Regulation (analysed) of CD34
4) Confidence 0.08 Published 2010 Journal Cancer Cell Int Section Body Doc Link PMC2902462 Disease Relevance 0.60 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox